CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 163 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $659 | -95.6% | 12,500 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $15,000 | -37.5% | 12,500 | -5.0% | 0.01% | -40.0% |
| Q2 2022 | $24,000 | +84.6% | 13,153 | +97.7% | 0.02% | +150.0% |
| Q1 2022 | $13,000 | -27.8% | 6,653 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $18,000 | -40.0% | 6,653 | 0.0% | 0.01% | -52.6% |
| Q3 2021 | $30,000 | +66.7% | 6,653 | +111.0% | 0.02% | +72.7% |
| Q2 2021 | $18,000 | -18.2% | 3,153 | 0.0% | 0.01% | -31.2% |
| Q1 2021 | $22,000 | +214.3% | 3,153 | +110.2% | 0.02% | +166.7% |
| Q4 2020 | $7,000 | -22.2% | 1,500 | 0.0% | 0.01% | -33.3% |
| Q3 2020 | $9,000 | – | 1,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |